Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from PfizerBioNTech

Here’s what you need to know about new Covid shots

The newest CDC recommendations will make a new shots available as early as this week.

Politico

FDA greenlights updated mRNA Covid vaccines

The agency's decision on Monday sets up shots to be rolled out later this month.

Politico

Poor countries face vaccine inequity

Vaccination is a global strategy, yet many low-income countries can't access then, perpetuating the pandemic

Salon

From analysis to the latest developments in health,
read the most diverse news in one place.

FDA recommends updated target for fall Covid boosters

The agency followed the guidance of its independent advisory committee, which identified a commonly circulating strain of the SARS-CoV-2 virus.

Politico

mRNA technology beat COVID-19, can it do the same for pancreatic cancer?

Half the pancreatic cancer patients in a new clinical trial were alive and cancer free after 18 months. Most usually die within three months.

The New Daily

China approves first domestic mRNA vaccine for Covid-19

Beijing (AFP) - China has approved its first locally developed messenger RNA (mRNA) vaccine against Covid-19, its manufacturer said Wednesday, months after the relaxation of strict Covid-zero regulations sparked a surge in cases.

AFP

Moderna, Pfizer and BioNTech Covid vaccine patent dispute heads to 2024 trial

US firm Moderna is suing its competitors for alleged patent infringement in relation to their Comirnaty vaccine.

The Independent UK

Read news from The Economist, FT, and more,
with one subscription

Bivalent COVID vaccines have now been in use for a few months – here's how they're stacking up against omicron

Vaccines have played a major role in mitigating the harms of the COVID pandemic since their rollout began just over two years ago. They’re estimated to have saved tens of millions of lives around the globe.

The Conversation

Getting vaccinated this holiday season? Here’s how to stay up-to-date on your COVID shots

DALLAS — Staying on schedule with the COVID-19 vaccine can feel like chasing a moving target.

Tribune News Service

EU watchdog backs Sanofi Covid booster jab

The Hague (AFP) - The EU on Thursday approved a Covid booster vaccine by French drug maker Sanofi and Britain's GSK after it gave positive results against the Omicron variant in trials.

AFP

African scientists say Western aid to fight pandemic is backfiring. Here's their plan

Monkeypox is the latest case of how global health inequities persist. Vaccines went to the rich world while Africa lacks access. African scientists call for a bold plan to protect against pathogens.

WEKU

Biden officials to get key data on new Covid booster's effectiveness

The update comes amid anxieties about the administration's effort to promote the newest vaccination as an upgrade over the original.

Politico

Fla. surgeon general's anti-vax warning

"This study is too flawed to be used to set policy on the mRNA vaccines in younger males," one expert said

Salon

How the new bivalent Covid vaccines work

Paris (AFP) - France became the latest country on Tuesday to authorise new Covid-19 vaccines that have been updated to target Omicron subvariants ahead of autumn booster campaign.

AFP

Get all your
news in one place.

100’s of premium titles.
One news app.

Inverse

Covid-19 boosters: Immunologists answer 5 key questions about the new shots

What is different about the updated booster shots? Two scientists offer their expertise to answer five questions about the shots.

Daily Mirror

When will Omicron boosters be available? Who is eligible for Covid jab and how to book

The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a second Coronavirus booster vaccine to target the Omicron variant ahead of the autumn booster programme

The Independent UK

Pfizer/BioNTech Covid-19 booster approved by UK medicines regulator

The vaccine targets both the original strain of coronavirus and the Omicron variant.

The Conversation

Will omicron-specific booster shots be more effective at combating COVID-19? 5 questions answered

On Sept. 1, 2022, the Centers for Disease Control and Prevention endorsed the use of updated COVID-19 booster shots that are specifically tailored to combat the two most prevalent omicron subvariants, BA.4 and BA.5. The decision comes just a day after the Food and Drug Administration’s emergency use authorization of…

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

FDA Approves Updated COVID-19 Booster Shots

But does everyone really need to get boosted?

AFP

US approves shots targeting Omicron

Washington (AFP) - US officials Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, hoping to contain a new wave of feared contagions this winter.

AFP

US approves updated Pfizer, Moderna shots targeting Omicron

Washington (AFP) - US health officials on Wednesday authorized updated Covid-19 vaccinations by Moderna and Pfizer-BioNTech that specifically target the latest strains of the Omicron variant, with the goal of jump-starting a new booster campaign.

Asharq Al-Awsat

Moderna Sues Pfizer/BioNTech for Patent Infringement over COVID Vaccine

Moderna sued Pfizer and its German partner BioNTech on Friday for patent infringement in the development of the first COVID-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic. Pfizer shares fell nearly 1%, while BioNTech US-listed shares were down about 1.5%…

The Independent UK

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

The vaccine maker said it had filed patent infringement lawsuits in the US and Germany.

Evening Standard

Moderna sues Pfizer/BioNTech alleging patent infringement over Covid vaccine

Moderna seeks unspecified damages in lawsuit over rivals’ jab

Bangkok Post

Moderna sues Pfizer over Covid vaccine

Moderna is suing Pfizer and its German partner BioNTech for patent infringement in the development of the first Covid-19 vaccine approved in the United States, alleging they copied technology that Moderna developed years before the pandemic.

1 2

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

311 stories

Centers for Disease Control and Prevention

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.